by Jordana Choucair | Jan 10, 2023 | Public Health/Prevention
The Biden administration may let the U.S. COVID-19 Public Health Emergency (PHE) declaration expire as early as the Spring. Under the current tentative plan, health officials will quietly renew the emergency declaration for another 90 days before its scheduled...
by Jordana Choucair | Jan 9, 2023 | Life Sciences
The Food and Drug Administration on Friday approved Leqembi – a new Alzheimer’s disease treatment that moderately slows cognitive decline in people with early-stage disease. Eisai Co., the Japanese pharmaceutical company that developed the drug with Biogen Inc., said...
by Jordana Choucair | Jan 9, 2023 | Life Sciences
Moderna Inc. said it pulled in $18.4 billion in COVID-19 vaccine sales last year, hitting its 2022 revenue forecast for the products. The company forecasted a minimum of $5 billion of sales this year. (Article here)
by Jordana Choucair | Jan 9, 2023 | Payers
Elevance Health and a coalition of other Blue Cross and Blue Shield carriers launched Synergie Medication Collective, an independent company that seeks to improve affordability and access to costly specialty drugs. The company will effectively serve as a group...
by Jordana Choucair | Jan 9, 2023 | Public Health/Prevention
The American Academy of Pediatrics (AAP) updated its recommendations on treating childhood obesity for the first time in 15 years. The new guidelines emphasize that obesity is a complex and chronic condition and that intensive behavioral and lifestyle changes should...
Recent Comments